TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer
Sifang Feng1, Juan Zhao2, Ting Yang2
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Abstract:
Myeloid-derived suppressor cells (MDSCs) contribute to tumor immune evasion, and have been identified as immunosuppressive cells in cervical cancer. The effect of TMPRSS11D (transmembrane serine protease 11D) in some cancers has been reported, but its role in immune escape of cervical cancer is still unclear. This study aims to elucidate the regulatory mechanism of TMPRSS11D on the immunosuppressive function of MDSCs in cervical cancer. Our data showed that the proportion of polymorphonucleoid MDSCs (PMN-MDSCs), the contents of immunosuppressive factors (including INOS, IDO, and ARG-1) secreted by MDSCs, and TMPRSS11D mRNA level in peripheral blood mononuclear cells (PBMCs) of malignant cervical cancer patients was significantly higher than that of benign tumor patients. Next, CD3+ T cells from PBMCs of cervical cancer patients were stimulated with anti-CD3 and anti-CD28, and then co-cultured with PMN-MDSCs from the same donors at a ratio of 1:2 for 3 days. PMN-MDSCs from malignant tumors produced more ROS, while TMPRSS11D knockdown blocked ROS production. PMN-MDSCs inhibited T cell proliferation and IFN-γ production, while silencing TMPRSS11D in PMN-MDSCs hindered the immunosuppressive effect of PMN-MDSCs. Mechanistically, TMPRSS11D bound to ALR (Augmenter of liver regeneration) and negatively regulated ALR expression, inducing ER stress in PMN-MDSCs, thereby enhancing the immunosuppressive effect of PMN-MDSCs on T cells. Additionally, mouse xenograft tumor assay was conducted to assess the role of TMPRSS11D in tumor growth and MDSC accumulation in vivo. Silencing TMPRSS11D impeded the growth of cervical cancer xenografts and reduced the accumulation of MDSCs in tumor tissues. In conclusion, TMPRSS11D induced ER stress in MDSCs through negative regulation of ALR, thus enhancing the immunosuppressive effect of MDSCs on T cells, so as to promote the growth of cervical cancer tumors.
Insights
Transmembrane serine protease 11D (TMPRSS11D) promotes cervical cancer immune evasion by enhancing myeloid-derived suppressor cell (MDSC) immunosuppression. Silencing TMPRSS11D reduces tumor growth and MDSC accumulation, offering a potential therapeutic target.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Myeloid-derived suppressor cells (MDSCs) are key players in tumor immune evasion, particularly in cervical cancer.
- The role of Transmembrane serine protease 11D (TMPRSS11D) in cervical cancer's immune escape remains largely unknown.
- Understanding TMPRSS11D's mechanism in MDSC immunosuppression is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the regulatory mechanism of TMPRSS11D on the immunosuppressive function of MDSCs in cervical cancer.
- To determine if TMPRSS11D influences MDSC-mediated T cell inhibition.
- To explore TMPRSS11D's impact on cervical cancer progression in vivo.
Main Methods:
- Comparative analysis of MDSC markers and TMPRSS11D expression in cervical cancer patients versus benign tumor patients.
- In vitro co-culture assays of T cells and MDSCs with TMPRSS11D knockdown.
- Assessment of reactive oxygen species (ROS) production, T cell proliferation, and IFN-γ levels.
- In vivo mouse xenograft models to evaluate TMPRSS11D's effect on tumor growth and MDSC infiltration.
Main Results:
- Malignant cervical cancer patients exhibited higher PMN-MDSC proportions, immunosuppressive factors, and TMPRSS11D mRNA levels.
- TMPRSS11D knockdown in MDSCs reduced ROS production and hindered their immunosuppressive capacity on T cells.
- TMPRSS11D negatively regulated ALR expression, induced ER stress in MDSCs, and promoted cervical cancer growth in vivo.
Conclusions:
- TMPRSS11D enhances MDSC-mediated immunosuppression in cervical cancer by inducing ER stress via ALR downregulation.
- Targeting TMPRSS11D may represent a promising strategy to overcome immune evasion and inhibit cervical cancer progression.
- Further research into TMPRSS11D's molecular pathways could reveal new therapeutic avenues for cervical cancer treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
The Tumor Microenvironment
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Induced Pluripotent Stem Cells
Somatic...
Mesenchymal Stem Cells


